Dangers of a False Sense of Security in a Huge Mastoid Cholesteatoma With Skull Base Erosion and Cerebrospinal Fluid Leakage

The author reports a case involving a 59-year-old man with delayed presentation of a huge mastoid cholesteatoma complicated by skull base erosion and cerebrospinal fluid leakage. Delayed presentation of this disease entity can have negative health consequences for patients. Regular otologic examinations, audiologic follow-up, and imaging examinations are viewed as the most effective strategies for the prevention of this type of situation. Early recognition of cholesteatomas is essential, as appropriate and timely treatment can prevent this rare comorbid condition from becoming fatal.

[1]  A. Hara,et al.  Cholesteatoma Mimicking Facial Neurinoma: A Case Report , 2017 .

[2]  A. Shiao,et al.  Increased Risk of Depression in Patients with Cholesteatoma: A 3-year Nationwide Population-Based Retrospective Cohort Study , 2017 .

[3]  C. Kuo,et al.  Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma: A Preliminary Report , 2017 .

[4]  H. Sudhoff,et al.  Updates and Knowledge Gaps in Cholesteatoma Research , 2015, BioMed research international.

[5]  C. Kuo.  Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research , 2015, The Laryngoscope.

[6]  A. Shiao,et al.  Mastoid Obliteration for Pediatric Suppurative Cholesteatoma: Long-Term Safety and Sustained Effectiveness after 30 Years' Experience with Cartilage Obliteration , 2014, Audiology and Neurotology.

[7]  Ralf Hofestädt,et al.  Identification of Novel Cholesteatoma-Related Gene Expression Signatures Using Full-Genome Microarrays , 2012, PloS one.

[8]  W. Liao,et al.  How long is long enough to follow up children after cholesteatoma surgery? A 29‐year study , 2012, The Laryngoscope.

[9]  M. Paksoy,et al.  Myeloperoxydase activity in the pathogenesis of cholesteatoma , 2010, Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India.

[10]  L. Meurer,et al.  Comparison of acquired cholesteatoma between pediatric and adult patients , 2009, European Archives of Oto-Rhino-Laryngology.

[11]  Y. Izumi,et al.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. , 2006, The American journal of pathology.

[12]  J. Jeong,et al.  Expression of RANKL and OPG in Middle Ear Cholesteatoma Tissue , 2006, The Laryngoscope.

[13]  S. Klebanoff.  Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[14]  M. Taylor,et al.  Management of Cerebrospinal Fluid Leaks Involving the Temporal Bone: Report on 92 Patients , 2003, The Laryngoscope.

[15]  M. Abramson,et al.  Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma. , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[16]  R. Yuasa,et al.  Organic Acids and Anaerobic Microorganisms in the Contents of the Cholesteatoma SAC , 1983, The Annals of otology, rhinology, and laryngology.

[17]  I. Ise,et al.  Bone destruction due to the rupture of a cholesteatoma sac: A pathogenesis of bone destruction in aural cholesteatoma , 1980, The Laryngoscope.

[18]  J. Ogura,et al.  The effect of cholesteatosis on bone. , 1951, Transactions of the American Otological Society.